Picture of Dispensa logo

DISP Dispensa News Story

0.000.00%
gb flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro CapValue Trap

Subsidiary Acquisition

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230213:nRSM6987Pa&default-theme=true

RNS Number : 6987P  Zamaz PLC  13 February 2023

13 February 2023

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF
REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT
TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK
MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS
DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

 

 

Zamaz plc

"Zamaz" or "the Company"

 

Acquisition by Bella Dispensa

 

Zamaz wholly owned subsidiary Bella Dispensa acquires Dallatte Italia srl for
€1m, further strengthening its growing portfolio of premium Italian
e-commerce food brands

 

Zamaz Plc, the London-based international e-commerce and retail technology
brand aggregator, is pleased to announce that its wholly owned subsidiary,
Bella Dispensa, has acquired the entire issued share capital of Dallatte
Italia srl ("Dallatte").

 

Dallatte, based in Piedmont, Italy, is a manufacturer and distributor of
premium dairy products using natural ingredients including ice cream and
pastries, milk, butter and cooking cream, fresh and dry pastries and frozen
filled pasta. The Dallatte brand is synonymous with "Italian Food Excellence"
and has distribution outlets across Europe.

 

Dallatte was founded in 2019 by a group of investors led by the Baravalle
family who have significant experience in food brand development and
distribution across Europe and internationally.  Following a period of
extensive product research and development during which time it created a
portfolio of over 60 products, Dallatte commenced trading in 2022, achieving
sales of over €1.3million and break-even profit in its first year from
offline sales.  It expects to achieve positive growth in sales and positive
operating margin in 2023, its second year of operations, as it diversifies
into online sales and expands its offline partnerships.  At year-end December
2022, it had estimated net assets in excess of €1.5million. The
consideration paid by Bella Dispensa for the acquisition was €1 million.

 

Acquisition Rationale

 

This latest acquisition, further re-inforces Zamaz' stated strategy of owning,
managing and investing in its subsidiaries' owned brand portfolio, thereby
reducing licensing royalties and significantly increasing shareholder value.
For Bella Dispensa, the acquisition further strengthens its position as a
major operator in the premium e-commerce "Made in Italy" food sector, where
the online B2C food & grocery eCommerce sector has increased
significantly; from €0.8billion in 2017 to €4.8billion in 2022*.

 

By leveraging its knowledge of retail technology, mining and analysing data
from online platforms to provide insights into consumer shopping behaviour and
trends, Zamaz and Bella Dispensa are working together on the exciting
opportunity to capitalise on the rapid adoption of Ecommerce in Italy and the
increasing trend in the country towards online grocery shopping.

 

Daniele Besnati, CEO of Zamaz and Bella Dispensa, commented:

"Dallatte is a fast growing company in a growth sector of the e-commerce
premium foods industry. Its name was inspired by Dario Osella, who, with Luca
Baravalle, the founder and head of brand development, are together well known
in the Italian food sector, in particular in Piemonte, helping it to achieve
its "Italian Excellence" status internationally.

 

"We expect the acquisition to help Bella Dispensa grow average spend per
customer and improve margins as we provide an ever-increasing and compelling
product choice to our customers seeking premium food products. At the same
time, this acquisition helps us to expand our customer base."

 

Martin Groak, Chairman of Zamaz plc added:

"Bella Dispensa has a key role to play in achieving Zamaz' long-term,
international growth ambitions. The Italian e-commerce industry is rapidly
expanding and innovating, and the Italian food theme is attractive to a wide
and global audience. The acquisition of Dallatte delivers another boost to
group revenue and is a tangible demonstration of Zamaz' portfolio strategy in
action; aligning with growing markets and consumer categories whilst
maintaining premium quality".

 

Advisers to the acquisition:

Innovative Finance, corporate adviser to Zamaz/Bella Dispensa
www.innovfinance.com (http://www.innovfinance.com)

Piergiorgio Sposato, Tonucci and Partners were legal advisers www.tonucci.com
(http://www.tonucci.com)

 

 

* Source of data: Statista, Italy published on 28 January 2022

 

-     Ends -

 

Enquiries:

 Zamaz plc                        www.zamaz.tech

 Daniele Besnati ,CEO             c/o Walbrook PR Limited
 Walbrook PR Limited

 Paul Vann/Nick Rome/Joe Walker   Tel: 020 7933 8780

                                  or 07768 807631

                                  zamaz@walbrookpr.com

Zamaz plc is a technology driven e-commerce business that originates,
acquires or licenses, operates and scales small and medium-sized brands with
category-winning products on global marketplaces. With ever prolific customer
data sources, the advent of turnkey e-commerce website platforms, such as
Shopify, and a thriving ecosystem of third-party software integrators, the
options available to launch and build brands that can be marketed, sold, and
shipped online quickly and globally with limited risk have never been more
compelling. Such marketplaces, led by Amazon and eBay, also provide connection
to millions of consumers, and have become a first-choice route-to-market for a
generation of micro and small and medium-sized enterprise businesses.

Zamaz mines and analyses data from such online retail technology platforms
which provide significant insights into consumer shopping behaviour and trends
and enable the business to deploy, market and sell an optimised portfolio of
brands, products, packs and prices aligned with active, real-time consumer
needs and demands principally on UK and EU Amazon marketplaces.

About Bella Dispensa

Bella Dispensa, a wholly-owned subsidiary of Zamaz, is an Italian-based online
retailer of gourmet Italian food products which operates in one of the fastest
growing online sectors, grocery shopping. The extensive relationships that
Bella Dispensa enjoys with its niche food suppliers makes it a strong addition
to the Zamaz Brand Portfolio and will give Zamaz the opportunity to showcase
and sell Bella Dispensa sourced products on its online platform.

 

Bella Dispensa has already made two acquisitions since Zamaz listed on the
Main Market of the London Stock Exchange: Ecocarni, a purveyor of premium
quality meats and associated products sourced from Italy and Argentina to both
wholesale and retail customers, from its flagship store in Milan and
Eccellenze S.r.l. which has a retail store located on Milan's prestigious
Corso Venezia, one of the city's most exclusive and elegant avenues, being
part of the upscale Quadrilatero della moda shopping district. Recently
established in Q4 2021, Eccellenze has grown rapidly, and now offers over
1,000 premium quality food products in-store, including cheese, pasta, wine
and oil. Its highly experienced management team has also developed a unique
eno-gastronomic "lifestyle shopping experience" for its growing, highly
discerning client base.

.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACQUORBRONUUARR

Recent news on Dispensa

See all news